BioHarvest Sciences (NasdaqGM:BHST) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsBar Dichter - CFOIlan Sobel - CEOJustin Meiklem - Head of Investor RelationsZaki Rakib - ChairmanConference Call ParticipantsAnthony Vendetti - Executive Managing Director and Director of Research and Senior Healthcare AnalystMatt Hewitt - Senior Research Analyst on HealthcareSean McGowan - Managing Director and Senior Research AnalystSusan Anderson - Managing Director and Senior AnalystOperatorI will no ...

BioHarvest Sciences (NasdaqGM:BHST) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Company ParticipantsBar Dichter - CFOIlan Sobel - CEOJustin Meiklem - Head of Investor RelationsZaki Rakib - ChairmanConference Call ParticipantsAnthony Vendetti - Executive Managing Director and Director of Research and Senior Healthcare AnalystMatt Hewitt - Senior Research Analyst on HealthcareSean McGowan - Managing Director and Senior Research AnalystSusan Anderson - Managing Director and Senior AnalystOperatorI will no ...

BioHarvest Sciences (NasdaqGM:BHST) Q4 2025 Earnings call March 31, 2026 04:30 PM ET Speaker5I will now hand the call over to Justin Meacham, Head of Investor Relations. Please go ahead.Speaker3Greetings. With us on the call are Dr. Zaki Rakib, Chairman, Ilan Sobel, Chief Executive Officer, and Bar Dichter, Chief Financial Officer. Before we begin, I'd like to remind you that management will be making projections and forward-looking statements on the call today regarding future events. Any statements that a ...

Group 1 - The article does not provide any specific investment advice or recommendations, emphasizing that the content is for informational purposes only [1] - It highlights the importance of considering individual circumstances and seeking independent financial advice before making investment decisions [2] Group 2 - The company receives annual cash compensation of up to $25,000 for publishing services related to BioHarvest Sciences Inc [2]

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 26, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a biotechnology company pioneering its proprietary Botanical Synthesis™ platform, today announced that its VINIA® brand has achieved the position of the #1 Resveratrol Polyphenol Nutraceutical Brand in the United States*.VINIA's leadership position is driven by its clinically demonstrated ability to increase arterial dilation, improving bl ...

Core Insights - BioHarvest Sciences achieved a significant milestone in 2025, marking its first full year as a NASDAQ-listed company with an annualized revenue run rate exceeding US$36 million and gross margins above 60% [1] - The company is focused on expanding its D2C Products and CDMO Services business units, aiming for continued growth and achieving adjusted EBITDA breakeven in the near term [1] D2C Products Business - The D2C Products business, particularly the VINIA® brand, has seen aggressive growth and product diversification, leveraging the 'VINIA Inside' strategy to enhance brand awareness and market penetration [2] - The VINIA Blood Flow Hydration Solution has received positive consumer feedback and is positioned to capture a share of the US$13 billion Electrolyte Hydration market [3] - Active users of VINIA products have exceeded 85,000, with over 90% of purchases being subscription-based, indicating a strong and predictable revenue stream [4] CDMO Services Division - The CDMO Services division reached a critical inflection point in 2025, securing partnerships across various industries and validating the commercial relevance of its Botanical Synthesis platform [5] - The division is working on two major new plant-based compounds, including a fragrance compound and a saffron-derived compound, with significant market potential [6] - The expectation is that CDMO revenues will surpass those of the Products division as the business continues to scale [6] Financial Strength and Growth - The company improved its balance sheet in 2025, raising approximately US$30.8 million through various financing methods, positioning itself for further growth and efficiency [7] - Increased analyst coverage and trading volume following the NASDAQ listing are seen as positive indicators for achieving a fair market valuation [8] - BioHarvest is fully funded for operational objectives and strategic capital investments, including the development of a new corporate campus and expanded manufacturing facilities [9] Future Priorities - The company's priorities include accelerating revenue growth, expanding margins, and reaching adjusted EBITDA breakeven while executing against a growing CDMO pipeline and expanding the VINIA product ecosystem [11]

Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content delivered by the team includes insights across various sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans to maintain quality and best practices in content production [5]

Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights into sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is committed to adopting technology to enhance its content creation and workflow processes [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all published content is edited and authored by humans [5]